99mTc-MIBI Brain SPECT to discriminate between tumor infiltration and brain abscess in cases of computed tomography and magnetic resonance unconvincing. Case Presentation
Vol. 32 No. 1 (2016), Clinical Cases
Vol. 32 No. 1 (2016)

99mTc-MIBI Brain SPECT to discriminate between tumor infiltration and brain abscess in cases of computed tomography and magnetic resonance unconvincing. Case Presentation

Clinical Cases
https://doi.org/10.22379/2422402275
Published 2015-11-12
Roberto León Castellón
Hospital Clínico Quirúrgico Hermanos Ameijeiras
Kali Cepero Llauger
Hospital Clínico Quirúrgico Hermanos Ameijeiras
Carmen Rodríguez Rodríguez
Hospital Clínico Quirúrgico Hermanos Ameijeiras
Mayte Castro Jiménez
Hospital Clínico Quirúrgico Hermanos Ameijeiras
Leda Fernández Cue
Hospital Clínico Quirúrgico Hermanos Ameijeiras
Adlin López Díaz
Hospital Clínico Quirúrgico Hermanos Ameijeiras
Juan Miguel Martín Escuela
PDF (Español)
HTML (Español)

Keywords

Brain abscess
Brain SPECT. 99mTc - MIBI (MeSH)

Abstract

The differentiation between brain abscess and brain metastasis in patients with some grade of immune suppression and hematological neoplasm is difficult in some situations. Functional studies like Single-Photon Emission Tomography (SPECT) and Positron Emission Tomography (PET) are useful for this purpose. We present the case of a patient with diagnosis of chronic myelogenous leukemia in blast crisis that a diagnosis of brain abscess was made. The diagnosis had a base in 99mTc - MIBI brain SPECT did not show MIBI uptake and the good treatment response to antibiotics when brain CT scan and MRI were not conclusive. Attending to the SPECT result, chemotherapy was postponed because of probably fatal complications in this patient with brain abscess.

https://doi.org/10.22379/2422402275

PDF (Español)
HTML (Español)

References

OMURO A, LEITE C, MOKHTARI K, DELATTRE JY. Pitfalls in the diagnosis of brain tumours. Lancet Neurol. 2006. 5(11): 937-948.

HOFFMAN R, BENZ EJ., SILBERSTEIN LE., HESLOP HE., WEITZ JI., ANASTASI J. Chronic Myeloid Leukemia. En: HOFFMAN R. Hematology: Basic principles and practice. Sixth Edition. Philadelphia, PA. Elseiver 2013 981 -84.

BRECCIAA, ALIMENAA G, BACCARANIB M, BOCCHIAC M, DI RAIMONDO F, GAMBACORTI-PASSERINIE C, ET AL. Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome. Crit Rev Oncol Hematol. 2014;90(3):181- 189.

SHANKAR V. Molecular Imaging. Radiopharmaceuticals for PET and SPECT. Springer-Verlag Berlin Heidelberg, Springer Dordrecht Heidelberg London New York, ISBN 978-3-540-76734-3. 2009; 1:3.

CULVER J, AKERS W, ACHILEFU S. Multimodality molecular imaging with combined optical and SPECT/PET modalities. J Nucl Med. 2008; 49(2):169-72.

FAN YX, LUO RC, LI GP, HUANG K. Diagnostic value of 99mTc-MIBI brain SPECT for brain glioma. Di Yi Jun Yi Da Xue Xue Bao. 2004; 24(10):1184-5.

GÓMEZ-RÍO M, RODRÍGUEZ-FERNÁNDEZ A, RAMOS-FONT C, LÓPEZ-RAMÍREZ E, LLAMAS-ELVIRA JM. Diagnostic accuracy of (201) Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence. Eur J Nucl Med Mol Imaging. 2008; 35:( 8)966-75.

DELTUVA VP, JURKIEN? N, KULAKIEN? I, BUNEVI?IUS A, MATUKEVI?IUS A, TAMAŠAUSKAS A. Introduction of novel semiquantitative evaluation of (99m)Tc-MIBISPECT before and after treatment of glioma. Medicina (Kaunas).2012; 48(1):15-21.

ARBIZU J, DOMÍNGUEZ PD, DIEZ-VALLE R, VIGIL C, GARCÍA-EULATE R, ZUBIETA JL, ET AL. Neuroimagen de los tumores cerebrales. Rev Esp Med Nucl. 2011; 30(1):47- 65.

BUCERIUS J, AHMADZADEHFAR H, BIERSACK HANS-JÜRGEN. 99mTc-Sestamibi. Clinical Applications. Volumen. Edición. Berlin Heidelberg: Springer-Verlag; 2012. 8 -166.

MITSUTAKA F. Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin. Ann Nucl Med. 2004;18(2):79-95.

BERRY I, GAILLARD JF, GUO Z, CORDOLIANI YS, MASSIP P, MANELFE C, DANET B. Cerebral lesions in AIDS: what can be expected from scintigraphy? Cerebral tomographic scintigraphy using thallium-201: a contribution to the differential diagnosis of lymphomas and infectious lesions. J. Neuroradiol. 1995 Sep;22(3):218-28.

FAN YX, LUO RC, LI GP, HUANG K. Diagnostic value of 99mTc-MIBI brain SPECT for brain glioma. Academic journal of the first medical college of PLA, 2004;24(10):1184-1185.

NEUBAUER GS. Medicina nuclear e imágenes moleculares. Rev Med Clin Condes. 2013;24(1):157-168.

CECCHIN D, SCHIORLIN I, DELLA PUPPA A, LOMBARDI G, ZUCCHETTA P, BODANZA V.ET AL. Assessing Response Using -MIBI Early after Interstitial Chemotherapy with Carmustine- Loaded Polymers in Glioblastoma Multiforme: Preliminary Results. Bio Med research international, 2014, vol. 2014: 1. Article ID 684383.

DELTUVA VP, JURKIEN? N, KULAKIEN? I, BUNEVI?IUS A, MATUKEVI?IUS A, TAMAŠAUSKAS A. Introduction of novel semiquantitative evaluation of (99m)Tc-MIBI SPECT before and after treatment of glioma. Medicina (Kaunas). 2012;48(1):15 21.

MENAA LM, MARTÍNA F, BRAVOA C, SANTOSB AB, ESCABIAA MV, JIMÉNEZA IR. 99mTc-MIBI SPECT in the study of brain lymphoma. Rev Esp Med Nucl. 2011;30(6):380-381.

KRASZNAI ZT, TÓTH A, MIKECZ P, FODOR Z, SZABÓ G, GALUSKA L, ET AL. Pgp inhibition by UIC2 antibody can be followed in vitro by using tumordiagnostic radiotracers, 99mTc-MIBI and 18FDG. Eur J Pharm Sci. 2010;41(5): 665-9.

WEI CHEN, TIMOTHY CLOUGHESY, NIRAV KAMDAR, NAGICHETTIAR SATYAMURTHY, MARVIN BERGSNEIDER, LINDA LIAU, ET AL. Imaging Proliferation in Brain Tumors with 18F-FLT PET: Comparison with 18F-FDG. J Nucl Med 2005; 46 (6):945-952.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.